Queen Mary Hospital

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Bladder cancer
• Cervical cancer
• Head and neck cancer
• Lung cancer

Closed trials

• Completed

  Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

  NCT03674567· Phase 1/2· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Source